
News Articles for "Yaron Werber"
-
Dendreon expects solid 4Q Provenge revenue
Biotechnology company Dendreon anticipates better-than-expected fourth-quarter adjusted revenue for its prostate cancer therapy Provenge. The company said...
read more
